Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships advance the next generation of leaders

The Pasteur Foundation US and the Institut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred. Those excelling in science will have a rare opportunity to acquire business and financial acumen and will emerge with the skills required to become successful entrepreneurs in the public health environment, […]

thaipr.net

26 ก.ค. 66

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion on the approval of ORSERDU® (elacestrant) monotherapy, indicated for […]

thaipr.net

24 ก.ค. 66

Invivoscribe Announces FDA Approval of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with FLT3-ITD Positive AML for Treatment with VANFLYTA

Invivoscribe is excited to announce that the LeukoStrat® CDx FLT3 Mutation Assay has been approved by the U.S. Food and Drug Administration (FDA) to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) who may be eligible to receive treatment with Daiichi Sankyo’s VANFLYTA® (quizartinib). The LeukoStrat CDx FLT3 Mutation Assay identifies FLT3-ITD positive AML patients who […]

thaipr.net

21 ก.ค. 66

ADVANCEMENTS IN TREATMENT, DIAGNOSIS AND RISK REDUCTION STRATEGIES HIGHLIGHTED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2023 covered the breadth of Alzheimer’s disease and dementia research, including advancements in treatment, early and accurate diagnosis, and our understanding of risk factors for Alzheimer’s and other dementias. AAIC is the premier annual forum for presentation and discussion of the latest Alzheimer’s and dementia research. This…

thaipr.net

21 ก.ค. 66

Nearly 80% of Doctors Worldwide Mistakenly Believe Nicotine Causes Lung Cancer, Thwarting Efforts to Help One Billion Smokers Quit

Survey of more than 15,000 physicians in 11 countries uncovers need for further educationThe Foundation for a Smoke-Free World invites researchers  to propose new analysis & educational programs   A significant majority of doctors across the globe mistakenly attributes the negative health consequences of smoking to nicotine, directly jeopardizing advancements made in helping smokers quit, a survey funded […]

thaipr.net

20 ก.ค. 66

SIMPLE FINGER PRICK TEST EXEMPLIFIES ADVANCES IN ALZHEIMER’S DISEASE BLOOD TESTS

Key Takeaways: A simple, finger prick blood test — not so different from what people with diabetes do every day — shows promise in the ability to detect Alzheimer’s disease, according to research reported for the first time today at the Alzheimer’s Association International Conference® (AAIC®) 2023, in Amsterdam, Netherlands, and online. Advancements in technology and practice […]

thaipr.net

20 ก.ค. 66

GHA Accreditation Helps Position Dr. Sulaiman Al-Habib Hospital in Al Khobar as a Trusted Destination for Medical Travel

In a significant achievement that firmly underscores its commitment to the highest standards of healthcare, Dr. Sulaiman AL-Habib Hospital in AL Khobar, Saudi Arabia, has been awarded the distinguished Accreditation for Medical Travel Services by Global Healthcare Accreditation (GHA). This accolade validates HMG Al Khobar’s dedication to delivering an exceptional medical travel patient journey, from the initial […]

thaipr.net

19 ก.ค. 66

ALZHEIMER’S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023

The data reported today by Eli Lilly from the TRAILBLAZER-ALZ 2 clinical trial of donanemab in early symptomatic Alzheimer’s disease demonstrate an important  advancement in Alzheimer’s research and treatment. The full Phase 3 data was reported at the Alzheimer’s Association International Conference® (AAIC®) 2023, in Amsterdam, Netherlands, and online. The data were simultaneously published in the Journal of the American…

thaipr.net

18 ก.ค. 66

ICBA: Aspartame safe, reaffirm WHO and FAO

Aspartame-sweetened foods and beverages are safe, according to a definitive new finding issued jointly today (Thursday) by the World Health Organization (WHO) and the UN Food and Agriculture Organization (FAO). The WHO and FAO Joint Expert Committee on Food Additives (JECFA) reviewed decades of high-quality evidence and real-world consumption data, establishing an Acceptable Daily Intake (ADI) […]

thaipr.net

14 ก.ค. 66
1 33 34 35 36 37 128